121 related articles for article (PubMed ID: 28431913)
1. Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia.
Morin L; Vetrano DL; Grande G; Fratiglioni L; Fastbom J; Johnell K
J Am Med Dir Assoc; 2017 Jun; 18(6):551.e1-551.e7. PubMed ID: 28431913
[TBL] [Abstract][Full Text] [Related]
2. Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia.
Matlow JN; Bronskill SE; Gruneir A; Bell CM; Stall NM; Herrmann N; Seitz DP; Gill SS; Austin PC; Fischer HD; Fung K; Wu W; Rochon PA
J Am Geriatr Soc; 2017 Jul; 65(7):1535-1542. PubMed ID: 28369696
[TBL] [Abstract][Full Text] [Related]
3. Prescribing medications of questionable benefit prior to death: a retrospective study on older nursing home residents with and without dementia in Germany.
Rausch C; Hoffmann F
Eur J Clin Pharmacol; 2020 Jun; 76(6):877-885. PubMed ID: 32219538
[TBL] [Abstract][Full Text] [Related]
4. Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study.
Morin L; Vetrano DL; Rizzuto D; Calderón-Larrañaga A; Fastbom J; Johnell K
Am J Med; 2017 Aug; 130(8):927-936.e9. PubMed ID: 28454668
[TBL] [Abstract][Full Text] [Related]
5. How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study.
Morin L; Wastesson JW; Laroche ML; Fastbom J; Johnell K
Palliat Med; 2019 Sep; 33(8):1080-1090. PubMed ID: 31172885
[TBL] [Abstract][Full Text] [Related]
6. Use of medications of questionable benefit in advanced dementia.
Tjia J; Briesacher BA; Peterson D; Liu Q; Andrade SE; Mitchell SL
JAMA Intern Med; 2014 Nov; 174(11):1763-71. PubMed ID: 25201279
[TBL] [Abstract][Full Text] [Related]
7. Aggressiveness of End-of-Life Care for Hospitalized Individuals with Cancer with and without Dementia: A Nationwide Matched-Cohort Study in France.
Morin L; Beaussant Y; Aubry R; Fastbom J; Johnell K
J Am Geriatr Soc; 2016 Sep; 64(9):1851-7. PubMed ID: 27459579
[TBL] [Abstract][Full Text] [Related]
8. Is the level of education associated with transitions between care settings in older adults near the end of life? A nationwide, retrospective cohort study.
Kelfve S; Wastesson J; Fors S; Johnell K; Morin L
Palliat Med; 2018 Feb; 32(2):366-375. PubMed ID: 28952874
[TBL] [Abstract][Full Text] [Related]
9. Medication appropriateness for patients with dementia approaching the end of their life.
Chuang HY; Wen YW; Chen LK; Hsiao FY
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():65-74. PubMed ID: 28436189
[TBL] [Abstract][Full Text] [Related]
10. Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life.
Grande G; Morin L; Vetrano DL; Fastbom J; Johnell K
Drugs Aging; 2017 Jul; 34(7):529-533. PubMed ID: 28536907
[TBL] [Abstract][Full Text] [Related]
11. Medication use in nursing home residents with advanced dementia.
Blass DM; Black BS; Phillips H; Finucane T; Baker A; Loreck D; Rabins PV
Int J Geriatr Psychiatry; 2008 May; 23(5):490-6. PubMed ID: 17944007
[TBL] [Abstract][Full Text] [Related]
12. Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
Morin L; Todd A; Barclay S; Wastesson JW; Fastbom J; Johnell K
Cancer; 2019 Jul; 125(13):2309-2317. PubMed ID: 30906987
[TBL] [Abstract][Full Text] [Related]
13. How Chronic Is Polypharmacy in Old Age? A Longitudinal Nationwide Cohort Study.
Wastesson JW; Morin L; Laroche ML; Johnell K
J Am Geriatr Soc; 2019 Mar; 67(3):455-462. PubMed ID: 30575952
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapeutic management of dementia across settings of care.
Rattinger GB; Burcu M; Dutcher SK; Chhabra PT; Rosenberg PB; Simoni-Wastila L; Franey CS; Walker LD; Zuckerman IH
J Am Geriatr Soc; 2013 May; 61(5):723-33. PubMed ID: 23590231
[TBL] [Abstract][Full Text] [Related]
15. Educational disparities in antipsychotic drug use among older people with and without dementia in Sweden.
Wastesson JW; Ringbäck Weitoft G; Johnell K
Acta Psychiatr Scand; 2015 Jul; 132(1):20-8. PubMed ID: 25532774
[TBL] [Abstract][Full Text] [Related]
16. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus.
Morin L; Laroche ML; Vetrano DL; Fastbom J; Johnell K
Eur J Clin Pharmacol; 2018 Oct; 74(10):1333-1342. PubMed ID: 29934849
[TBL] [Abstract][Full Text] [Related]
17. Terminal care for persons with advanced dementia in the nursing home and home care settings.
Mitchell SL; Morris JN; Park PS; Fries BE
J Palliat Med; 2004 Dec; 7(6):808-16. PubMed ID: 15684848
[TBL] [Abstract][Full Text] [Related]
18. Use of antipsychotics, benzodiazepine derivatives, and dementia medication among older people with intellectual disability and/or autism spectrum disorder and dementia.
Axmon A; Kristensson J; Ahlström G; Midlöv P
Res Dev Disabil; 2017 Mar; 62():50-57. PubMed ID: 28110116
[TBL] [Abstract][Full Text] [Related]
19. Community-based palliative care is associated with reduced emergency department use by people with dementia in their last year of life: A retrospective cohort study.
Rosenwax L; Spilsbury K; Arendts G; McNamara B; Semmens J
Palliat Med; 2015 Sep; 29(8):727-36. PubMed ID: 25783598
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
